Skip to main content

Burak Zeybek, MD : Research

Critical Care Medicine Specialist, Cancer Specialist (Oncologist), Obstetrician / Gynecologist (OBGYN), Gynecologic Oncologist (Gynecological Cancer Specialist)

Rated 4.9 out of 5 stars
114 ratings 37 reviews
Additional languages:
Turkish
Photo of Burak Zeybek
(352) 733-0111 MyUFHealth

Research at a glance

Top areas of exploration

  • Pregnancy , 14 publications
  • Cell Line, Tumor , 10 publications
  • Uterine Neoplasms , 8 publications
  • Neoplasm Recurrence, Local , 7 publications

Research activity

81 publications

1,464 citations

Why is this important?

Active clinical trials

My publications

Filter publications

81 publications

2024

Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.

British journal of cancer

PubMed • Publisher's site

2022

Alterations in Pre/Post Oxygenator Flows Due to Fibrin Deposition in the CardioHelp System-A Case Report.

The journal of extra-corporeal technology

PubMed • Publisher's site

2022

Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.

British journal of cancer

PubMed • Publisher's site

2022

A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.

Cancer

PubMed • Publisher's site

2021

DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo.

Gynecologic oncology

PubMed • Publisher's site